Biotech companies are making a solid comeback following an extended slump as investors shift their focus back to value and ...

Drugmakers are making notable deals, biotech is coming back, and much of the worry about tariffs and interest rates has faded ...

On November 14, 2025, Bain Capital Life Sciences Investors, LLC disclosed a purchase of 520,310 shares of Cidara Therapeutics ...

On November 14, 2025, Bain Capital Life Sciences Investors, LLC, disclosed a full exit from Nuvalent ( NUVL +3.29%), reducing ...

UroGen Pharma Ltd. (NASDAQ:URGN) is one of the best small-cap biotech stocks to buy according to analysts.

The biotech sector, tracked by iShares Biotechnology ETF, rallied 40% in six months on rising M&A activity, still below ...

Of course, there are countless value stocks that are worth mentioning, but this is a concise list of the top 4 undervalued ...

Lilly will also gain certain rights to MeiraGTx’s proprietary riboswitch technology for use in gene editing in the eye. Under ...

Several biotech stocks have seen their strength fade over the past week, with their Momentum scores in Benzinga’s Edge Stock Rankings witnessing a significant decline. Top 4 Biotech Stocks With A Dip ...

Krystal Biotech drives Vyjuvek growth, premium margins, global expansion, a $1B goal, and pipeline data ahead with a $219.50 ...

Biotech stocks have performed well this year. The SPDR S&P Biotech ETF -- an industry benchmark -- is up 21% this year. Two ...

Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR), Assembly Biosciences Inc. (NASDAQ: ASMB), Atara Biotherapeutics Inc. (NASDAQ: ATRA), and Corcept Therapeutics Inc.‘s (NASDAQ: CORT) momentum percentile ...